📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Anti-Tuberculosis Activity of Three Carbapenems, Clofazimine and Nitazoxanide Using a Novel Ex Vivo Phenotypic Drug Susceptibility Model of Human Tuberculosis. (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/antibiotics11101274

PubMed Identifier: 36289932

Publication URI: http://europepmc.org/abstract/MED/36289932

Type: Journal Article/Review

Volume: 11

Parent Publication: Antibiotics (Basel, Switzerland)

Issue: 10

ISSN: 2079-6382